CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO and President acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Chief Legal Officer and EVP acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Henn Matthew R. acquired 7,500 shares (option exercise)
- 4 Exercise or conversion Chief Technology Officer & EVP acquired 12,500 shares (option exercise)
- 4 Open-market sale Chapman Marcus sold 3,400 shares at $3.91 ($13,297)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,888,888 shares at $2.25 ($19,999,998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 19 · 380 filings